SBI Securities’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
ACM
RA
BPC
AIC
SCM
SAM
SBI Securities's SOPH Position: Q2 2026 in Review
SBI Securities reduced its SOPHiA GENETICS (SOPH) stake by 27% in Q2 2026, selling an estimated $61 and leaving 33 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #3344.
SBI Securities first reported a position in SOPH in Q3 2025 and has held it in 4 quarters since. The position peaked at $223 in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.
- SBI Securities held 33 shares of SOPHiA GENETICS worth $190 as of Q2 2026.
- SBI Securities sold 12 SOPHiA GENETICS shares in Q2 2026, an estimated $61.
- SOPHiA GENETICS made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3344 holding.
- SBI Securities first reported a position in SOPHiA GENETICS in Q3 2025 and has held it in 4 quarters since.
- SBI Securities's SOPHiA GENETICS position peaked at $223 in Q1 2026.
- 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.
Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.